Investigación

Sarcomas e Histiocitosis

Buscador de publicaciones

Publicaciones

  • Sanchez-Guixe E, Muiños F, Pinheiro-Santin M, González-Huici V, Rodriguez-Hernandez CJ, Avgustinova A, Lavarino C, González- Pérez A, Mora J and López-Bigas N.

    Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues

    CANCER DISCOVERY . 14(6): 953-964. Nº de citas: 4

    [doi:10.1158/2159-8290.CD-23-1186]

  • Caballero R, Pasten A, Giménez C, Raquel Rodriguez Baladon, Carmona-Jiménez RM, Mora J, Valls-Esteve A, Lustig P, Lombardini F, Balsells S and Krauel L.

    Beyond Needles: Pioneering Pediatric Care with Virtual Reality (VR) for TIVAD Access in Oncology

    Cancers . 16(12): .

    [doi:10.3390/cancers16122187]

  • Cappellano A, Gorostegui M, Gonzalez-Ramella O, Filho NPC, Valencia D, Chantada L, Sampor C, Serrano MJ, Macedo C, Ramirez O, Sardinas S, Lezcano E, Calderón P, Gamboa Y, Fu L, Gómez W, Schelotto M, Ugaz C, Lobos P, Aguiar SDS, Moreno K, Palma J, Sánchez G, Moschella F, Gassant PYH, Velasquez T, Quintero K, Moreno F, Villarroel M, Fuentes Alabi S, Vasquez L, Challinor J and Chantada G.

    International Society of Paediatric Oncology (SIOP) Global Mapping Programme: Latin American Society of Pediatric Oncology (SLAOP) country-level report

    PEDIATRIC BLOOD & CANCER . 71(6): . Nº de citas: 2

    [doi:10.1002/pbc.30973]

  • Mora J, Climent A, Roldan-Molina M, Flores MC, Varo A, Pérez-Jaume S, Jou-Munoz C, Celma MS, Lazaro JJ, Cheung I, Castañeda-Heredia A, Gorostegui M, Rodriguez E, Chamorro S, Muñoz JP and Cheung NK.

    Desensitizing the autonomic nervous system to mitigate anti-GD2 monoclonal antibody side effects

    Frontiers in oncology . 14: 1380917-1380917.

    [doi:10.3389/fonc.2024.1380917]

  • Nieva G, Agulló N, Grande-Molina M, Adell NE, Tarrado X, Calvo-Duarte L, Valls-Esteve A, Krauel L, Fenollosa-Artés F, Teixidó R and Borròs S.

    Developing tuneable viscoelastic silicone gel-based inks for precise 3D printing of clinical phantoms

    Materials Advances . 5(9): 3706-3720. Nº de citas: 2

    [doi:10.1039/d4ma00011k]

  • Pasten A, Salvador-Alarcon C, Mora J, Martín Gimenez MP, Carrasco-Torrents R and Krauel L.

    Current Status of Fertility Preservation in Pediatric Oncology Patients

    CHILDREN-BASEL . 11(5): . Nº de citas: 1

    [doi:10.3390/children11050537]

  • Gorostegui M, Muñoz JP, Pérez-Jaume S, Simao-Rafael M, Cristina Larrosa Espinosa, Garraus-Oneca M, Salvador-Marcos N, Lavarino C, Krauel L, Mañe S, Castañeda-Heredia A and Mora J.

    Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy

    Cancers . 16(9): . Nº de citas: 1

    [doi:10.3390/cancers16091735]

  • Fresno Cañada C, Gispets Parcerisas J, Del Prado-Sanchez C, Puigventós E, Pérez-Jaume S, Salvador-Hernandez H, Llorca Cardeñosa A and Prat-Bartomeu J.

    DRI Triton SS-OCT applied to detect choroidal nodules in paediatric patients affected by NF1.

    Heliyon . 10(8): .

    [doi:10.1016/j.heliyon.2024.e29263]

  • Mora J, Modak S, Kinsey J, Ragsdale CE and Lazarus HM.

    GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma

    INTERNATIONAL JOURNAL OF CANCER . 154(8): 1340-1364. Nº de citas: 6

    [doi:10.1002/ijc.34815]

  • Villasante A, Corominas J, Alcon C, Garcia-Lizarribar A, Mora J, Lopez-Fanarraga M and Samitier J.

    Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model

    Cancers . 16(5): . Nº de citas: 1

    [doi:10.3390/cancers16051060]